Immunomodulatory effects of CM and its components were also demonstrated in clinical studies of chronic hepatitis B and patients with HCV by increasing IFN-γ and Th1 but decreasing IL-4 and Th2, as well as TNF-α level. The gene discussed is IL4; the disease is chronic hepatitis B virus infection.